
Network Pharmacology and Molecular Docking for Natural Product-Based Therapies in Gallbladder and Biliary Tract Cancers: Workflows, Pitfalls, and Translational Opportunities
<a href="https://news.google.com/rss/articles/CBMiswJBVV95cUxNY2xGTUdfdFhsTGVCa2Z6bE1UY2MyTEtJWHdGZFJKYVpzamRQOThpRmd4dl80SnNNVHFNUlNTSFBLSXFPc3luX200YzhrRkhsTGhhMC00ak1heVdvTXoxb01SdC0xNDREVzN4cnYtWDhfeTlkM2Rmanp5OE9hTVpFU0FiZmZXcEJtWWdVYnZtNTdCLXg3aEZZRXFwdnpVcGc4S2V5cng4NG9ZUEpnTUVUdzJkVDhyY21ORENJdjZOZVJhVkZ3Zk5scWxTMHhaQXhTMERqeVR5cTZmamxFY19zVkVtRGtkT214aGRPV3AtUFhzSVFWblpjOGpPOXJPY1BrSnVhdWdOOHRXM2ZIV3U4bmQtR3RlZUVGT1FlaXBfNEI5Nm9ycGwyZFF1WnhCZXNWY2dZ?oc=5" target="_blank">Network Pharmacology and Molecular Docking for Natural Product-Based Therapies in Gallbladder and Biliary Tract Cancers: Workflows, Pitfalls, and Translational Opportunities</a>&nbsp;&nbsp;<font color="#6f6f6f">The Cureus Journal of Medical Science</font>
